Page last updated: 2024-10-23

bisoprolol and Long QT Syndrome 1

bisoprolol has been researched along with Long QT Syndrome 1 in 1 studies

Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

Research Excerpts

ExcerptRelevanceReference
"Bisoprolol treatment results in QTc shortening in gene-positive LQT1 and LQT2 patients and is well tolerated during long-term administration."1.43Experience with bisoprolol in long-QT1 and long-QT2 syndrome. ( Adler, A; Al-Sabeq, B; Andrade, JG; Bennett, MT; Chakrabarti, S; Deyell, MW; Green, M; Kerr, CR; Klein, GJ; Krahn, AD; Laksman, ZW; Padfield, GJ; Steinberg, C; Yee, R; Yeung-Lai-Wah, JA, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Steinberg, C1
Padfield, GJ1
Al-Sabeq, B1
Adler, A1
Yeung-Lai-Wah, JA1
Kerr, CR1
Deyell, MW1
Andrade, JG1
Bennett, MT1
Yee, R1
Klein, GJ1
Green, M1
Laksman, ZW1
Krahn, AD1
Chakrabarti, S1

Other Studies

1 other study available for bisoprolol and Long QT Syndrome 1

ArticleYear
Experience with bisoprolol in long-QT1 and long-QT2 syndrome.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2016, Volume: 47, Issue:2

    Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Bisoprolol; Canada; Cardiotonic Agents; Cohort Studie

2016